...company to pursue other interests. Ford was SVP, head of global clinical operations, at the Merck Serono...

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...

...each tranche has not been disclosed. In 2013, the company was spun out from the Merck Serono...

...RheoSwitch technology. Under the original terms, Merck would have developed the CAR Ts post-IND (see "Merck Serono...

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...

...Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono S.A. In 2012, Merck Serono's...

...50% of the costs thereafter. Genmab also had recently regained rights to zanolimumab from the Merck Serono...

...and develop RNA-targeting therapies against undisclosed targets. In 2013, the fund spun Calypso out of Merck Serono...

...Extra, Feb. 6) . Prexton was the first spinout of the Entrepreneur Partnership Program of Merck Serono...

...principal. Kumar, who is based in the firm's Boston office, was a senior director at Merck Serono...